Épidémiologie des syndromes myéloprolifératifs chroniques

Harris, 2000, The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia November, 1997, Hematol J Off J Eur Haematol Assoc., 1, 53 Vardiman, 2009, The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes, Blood. 30 juill, 114, 937, 10.1182/blood-2009-03-209262 Rowley, 1973, Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining, Nature, 243, 290, 10.1038/243290a0 Le Guyader-Peyrou, 2016, Cancer incidence in France over the 1980-2012 period: Hematological malignancies, Rev d’Épidémiologie Santé Publique, 64, 103, 10.1016/j.respe.2015.12.017 Maynadie, 2011, Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d’Or (Burgundy France), Haematologica, 96, 55, 10.3324/haematol.2010.026252 Troussard, 2009, Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004, Rev Epidemiol Sante Publique, 57, 151, 10.1016/j.respe.2009.02.204 Roaldsnes, 2017, Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway, Eur J Haematol, 98, 85, 10.1111/ejh.12788 Moulard, 2014, Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union, Eur J Haematol. avr, 92, 289, 10.1111/ejh.12256 Deadmond, 2015, Changing incidence of myeloproliferative neoplasms: trends subgroup risk profiles in the U.S.A. 1973-2011, J Cancer Res Clin Oncol, 141, 2131, 10.1007/s00432-015-1983-5 Byun, 2016, Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004-2013, Ann Hematol, 27 Mehta, 2014, Epidemiology of myeloproliferative neoplasms in the United States, Leuk Lymphoma. mars, 55, 595, 10.3109/10428194.2013.813500 Girodon, 2009, Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study, Haematologica. juin, 94, 865, 10.3324/haematol.2008.004234 Srour, 2016, Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12, Br J Haematol. août, 174, 382, 10.1111/bjh.14061 Sant, 2010, Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project, Blood. 11 nov, 116, 3724, 10.1182/blood-2010-05-282632 Osca-Gelis, 2013, Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona Spain, Haematologica. août, 98, e95, 10.3324/haematol.2013.084061 Visser, 2012, Incidence, survival and prevalence of myeloid malignancies in Europe, Eur J Cancer Oxf Engl 1990, 48, 3257 Roman, 2016, Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15, Cancer Epidemiol. juin, 42, 186, 10.1016/j.canep.2016.03.011 Sant, 2014, Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study, Lancet Oncol. août, 15, 931, 10.1016/S1470-2045(14)70282-7 Price, 2014, Survival patterns in United States (US) medicare enrollees with non-CML myeloproliferative neoplasms (MPN), PloS One., 9, e90299, 10.1371/journal.pone.0090299 Osorio, 2016, Chronic myeloid leukaemia in Spain: Its presentation characteristics have changed Spanish section of the EUTOS population-based registry, Rev Clin Esp. sept, 216, 293, 10.1016/j.rce.2016.03.001 Monnereau A, Uhry Z, Bossard N, et al. Survie des personnes atteintes de cancer en France métropolitaine 1989-2013. Vol. 2. Institut de Veille Sanitaire, Saint-Maurice; 2016. Penot, 2015, Incidence of chronic myeloid leukemia and patient survival: results of five French population-based cancer registries 1980-2009, Leuk Lymphoma., 56, 1771, 10.3109/10428194.2014.974046 De Angelis, 1990, Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study, Eur J Cancer Oxf Engl Karalexi, 2016, Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America, Eur J Cancer Oxf Engl, 67, 183, 10.1016/j.ejca.2016.08.011